Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues-Reference-Cited by-同舟云学术

Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues

Published:2022-03-21 Issue:5 Volume:3 Page:581-594
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Feng Zijie^ORCID,He Xin^ORCID,Zhang Xuyao^ORCID,Wu Yuan^ORCID,Xing Bowen^ORCID,Knowles Alison,Shan Qiaonan,Miller Samuel,Hojnacki Taylor,Ma Jian,Katona Bryson W.,Gade Terence P. F.,Schrader Jörg,Metz David C.,June Carl H.^ORCID,Hua Xianxin^ORCID

Funder

Care for Carcinoid Foundation Research Grant; Neuroendocrine Tumor Research Foundation Accelerator Grant

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-022-00344-7.pdf

Reference64 articles.

1. Arnold, M. et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159, 335–349 (2020).

2. Hazama, S., Tamada, K., Yamaguchi, Y., Kawakami, Y. & Nagano, H. Current status of immunotherapy against gastrointestinal cancers and its biomarkers: perspective for precision immunotherapy. Ann. Gastroenterol. Surg. 2, 289–303 (2018).

3. Dasari, A. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3, 1335–1342 (2017).

4. Oberg, K. et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol. 43, 617–625 (2004).

5. Kulke, M. H. et al. Neuroendocrine tumors. J. Natl Compr. Canc. Netw. 10, 724–764 (2012).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy;Pathology - Research and Practice;2024-10

2. Variability in morphology and immunohistochemistry of Crohn’s disease-associated small bowel neoplasms: implications of Claudin 18 and Cadherin 17 expression for tumor-targeted immunotherapies;Virchows Archiv;2024-08-21

3. The Transcriptional Landscape of Coding and Noncoding RNAs in Recurrent and Nonrecurrent Colon Cancer;The American Journal of Pathology;2024-08

4. Gene therapy clinical trials worldwide to 2023—an update;The Journal of Gene Medicine;2024-08

5. Progress in the Utilization of Nanobody CAR-T Cell in Cancer Immunotherapy;Journal of Biomedical Nanotechnology;2024-08-01